Comparable stake leader
Heng Fai Ambrose Chan
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001834105.
Comparable stake leader
Heng Fai Ambrose Chan
Disclosed value leader
GEODE CAPITAL MANAGEMENT, LLC
Comparable rows
1/20
Latest evidence
07 Oct 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
1 of 20 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Heng Fai Ambrose Chan |
3/4/5
13D/G
Director, 10%+ Owner
|
2.9%
Reported 13D/G
· 02 Apr 2025
|
$17,350
32,112 shares
|
— | 07 Oct 2026 |
| DSS, INC. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$271,178
589,518 shares
|
-$398 | 22 Sep 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$526,316
93,915 shares
|
— | 30 Sep 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$413,028
73,755 shares
|
— | 30 Sep 2026 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$272,782
48,711 shares
|
— | 30 Sep 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
—
denominator unverified
|
$261,554
46,706 shares
|
— | 30 Sep 2026 |
| Frank D. Heuszel |
3/4/5
Chief Executive Officer, Director
|
—
denominator unverified
|
$219,783
97,344 shares
|
— | 05 Dec 2024 |
| Jason Grady |
3/4/5
Director
|
—
denominator unverified
|
$162,643
28,164 shares
|
-$32,505 | 07 Oct 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$58,233.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 723 | $0 | $398 | -$398 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 95,000 | $0 | $57,835 | -$57,835 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-11 of 11 reporting-owner rows connected to IMPACT BIOMEDICAL INC.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| DSS, INC. | 10%+ Owner | $271,178 | -$398 | -0.15% | Mixed | 22 Sep 2026 |
| Frank D. Heuszel | Chief Executive Officer, Director | $219,783 | Filing P/S | 05 Dec 2024 | ||
| Jason Grady | Director | $162,643 | -$32,505 | -17% | Mixed | 07 Oct 2026 |
| Todd D. Macko | Chief Financial Officer | $87,101 | -$25,330 | -23% | Mixed | 07 Oct 2026 |
| Heng Fai Ambrose Chan | Director, 10%+ Owner | $17,350 | Mixed | 07 Oct 2026 | ||
| Castel Berisford Hibbert | Director | $17,350 | Mixed | 07 Oct 2026 | ||
| Mark Suseck | Chief Operating Officer | $17,350 | Mixed | 07 Oct 2026 | ||
| Melissa Kaye Sims | Director | $17,350 | Mixed | 07 Oct 2026 | ||
| David K. Keene | Director | $17,350 | Mixed | 07 Oct 2026 | ||
| Elise Brownell | Director | $17,350 | Mixed | 07 Oct 2026 | ||
| Christian Thomas Zimmerman | Director | $17,350 | Mixed | 07 Oct 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Mark Suseck | IBO | Common Stock | Award | -11.5% | -4,170 | 32,112 | 07 Oct 2026 | Direct | ||
| Christian Thomas Zimmerman | IBO | Common Stock | Award | -11.5% | -4,170 | 32,112 | 07 Oct 2026 | Direct | ||
| Castel Berisford Hibbert | IBO | Common Stock | Award | -11.5% | -4,170 | 32,112 | 07 Oct 2026 | Direct | ||
| Melissa Kaye Sims | IBO | Common Stock | Award | -11.5% | -4,170 | 32,112 | 07 Oct 2026 | Direct | ||
| David K. Keene | IBO | Common Stock | Award | -11.5% | -4,170 | 32,112 | 07 Oct 2026 | Direct | ||
| Elise Brownell | IBO | Common Stock | Award | -11.5% | -4,170 | 32,112 | 07 Oct 2026 | Direct | ||
| Heng Fai Ambrose Chan | IBO | Common Stock | Award | -11.5% | -4,170 | 32,112 | 07 Oct 2026 | Direct | ||
| Jason Grady | IBO | Common Stock | Award | -12.9% | -4,170 | 28,164 | 07 Oct 2026 | Direct | ||
| Todd D. Macko | IBO | Common Stock | Award | -20.2% | -4,170 | 16,462 | 07 Oct 2026 | Direct | ||
| Dss, Inc. | IBO | Common Stock | Sale | -0.03% | -156 | 589,518 | 24 Sep 2026 | Direct | ||
| Dss, Inc. | IBO | Common Stock | Sale | -27 | 589,674 | 23 Sep 2026 | Direct | |||
| Dss, Inc. | IBO | Common Stock | Sale | -0.12% | -$398 | $0.5500 | -723 | 589,701 | 22 Sep 2026 | Direct |
| Todd D. Macko | IBO | Common Stock | Sale | -21.9% | -$24,369 | $0.5615 | -43,400 | 155,122 | 27 Mar 2026 | Direct |
| Todd D. Macko | IBO | Common Stock | Sale | -0.8% | -$961 | $0.6008 | -1,600 | 198,122 | 25 Mar 2026 | Direct |
| Jason Grady | IBO | Common Stock | Sale | -16.7% | -$32,505 | $0.6501 | -50,000 | 250,182 | 23 Mar 2026 | Direct |